NanoViricides Inc. (NNVC)

[Ubertino]

Ebola - [e-mail]

to me

People have been writing me about FujiFilm and their drug, ostensibly for Ebola although I haven’t seen any test results nor have I seen a PR about an alliance with a BSL-4 provider

The one thing that concerns me is that the drug is delivered orally

How do you give an oral medicine when you have a patient who is vomiting?

Vomiting is a hallmark of the disease

Intravenous administration of any drug will be difficult because it requires certain skills and puts the operator at risk. That’s why I would like to administer EbolaCide intramuscularly

Also, for all the companies to fulfill their obligations to the government for the money they’ve received over the years, they’ll have to ramp up manufacturing (if they can) and make as many doses as possible

I have a completely different strategy…that is get EbolaCide (if we find that it works in vivo) into between 100-1000 patients.That accomplishes the following for us:

Proof of concept

First in humans

Validation of the rapid development program

Moves us from a pre-clinical to a clinical biopharma

World-wide recognition

Only if we then get funding will we move this into production. Some of the companies have already gotten $100’s of millions. My fervent hope is that every single drug and vaccine works well. NanoViricides hits the jackpot if we just get success with a few patients.

Sincerely,

Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
[e-mail]
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange